The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Images in Clinical Medicine
PreviousPrevious
Volume 349:e20 November 20, 2003 Number 21
NextNext

Fabry's Disease

 

This Article
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation


View larger version (99K):
[in this window]
[in a new window]
 
A 30-year-old man had severe neuropathic pain that affected his hands and feet. Examination of his skin showed angiokeratomas that were particularly prominent in the groin and on the back (Panel A) but that were also present on the lips and palms. Examination of the optic fundi showed tortuous retinal arterioles (Panel B). He had heat intolerance and decreased sweating. The diagnosis of Fabry's disease was confirmed by the detection of reduced {alpha}-galactosidase A activity in peripheral leukocytes. He received carbamazepine for the neuropathic pain. Testing of renal function when the patient was 38 years of age showed a serum creatinine concentration of 1.1 mg per deciliter (97.2 µmol per liter), a creatinine clearance rate of 92 ml per minute per 1.73 m2 of body-surface area, and a protein excretion rate of 3.9 g per day. Renal biopsy showed an accumulation of toluidine blue staining in cellular inclusions that was prominent in glomerular podocytes and also present in distal tubular epithelial cells and extraglomerular vascular cells (Panel C, x80). Electron-microscopical examination of the glomerulus revealed podocytes bearing electron-dense lamellar bodies that represented secondary lysosomes containing glycolipid (Panel D, x3800). The patient is being treated with {alpha}-galactosidase A administered by intravenous infusion every two weeks. His symptoms have improved, although his renal function has continued to deteriorate, with a serum creatinine concentration now of 2.2 mg per deciliter (194.5 µmol per liter).

 

Jeffrey B. Kopp, M.D.
Raphael Schiffmann, M.D.
National Institutes of Health
Bethesda, MD 20892




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.